Board Meeting Agenda
The Board of Directors will consider and approve the following items:
- Unaudited Financial Results of the Company for the quarter and half year ended 30th September 2026, along with the Limited Review Report.
- Proposal for raising funds through issuance of one or more instruments including equity shares or warrants convertible into equity shares. The fundraising may be conducted through preferential issue, private placements, rights issue, or any other permitted methods or combination thereof, in compliance with SEBI (Issue of Capital and Disclosure Requirements) Regulations, 2018. This is subject to requisite approvals including shareholder and statutory approvals.
- Any other matter with the permission of the chair.
Trading Window Closure
As previously intimated via letter dated 29th September 2026, the Trading Window for dealing in the Equity Shares of the Company remains closed for all Connected/Designated Persons and their relatives. The closure period began on Thursday, 1st October 2026 and will continue until 48 hours after the declaration of the Unaudited Financial Results for the quarter and half year ended 30th September 2026. This closure is in accordance with the Company's Code of Conduct under SEBI (Prohibition of Insider Trading) Regulations, 2015.
Compliance Officer
Daya Dhavalbhai Savani, Company Secretary & Compliance Officer, signed the disclosure digitally on 27th October 2026 at 14:36:02 IST.